144 ·Filed May 14, 2026

CLOV

CLOVER HEALTH INVESTMENTS, CORP. /DE
BEARISH
Impact 5/10
Horizondays Processed4mo ago SEC0001959173-26-003605
Form 144 — notice of proposed sale of securities
Actionable Insight ▼ Bearish

A former CFO liquidating his entire stake after a sharp rally is a bearish signal. While the dollar amount is small relative to market cap, the clean-out nature and timing (immediately after a ~39% run-up) suggest the insider sees limited upside. Monitor for additional insider selling or a Form 4 filing confirming execution. The stock's recent momentum may pause on this news.

DirectionBearish
Confidencemedium
Horizondays
Final — all horizons settled through T+60d
CLOV ▲ +30.95% at T+60d
SHORT call ✗ call lost -30.95% · α vs SPY -27.36% · entry $3.49 → $4.57
Entry anchored
May 14, 03:20 PM ET
via exchange tick
T+1d
-0.57%
call +0.57% · α -0.65%
$3.47
settled 5mo ago
T+5d
+3.15%
call -3.15% · α -3.87%
$3.60
settled 4mo ago
T+20d
+35.53%
call -35.53% · α -36.39%
$4.73
settled 4mo ago
T+60d
+30.95%
call -30.95% · α -27.36%
$4.57
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Former CFO Peter J. Kuipers filed a Form 144 to sell 886,341 shares of Clover Health (CLOV) worth approximately $3.06M, representing his entire remaining stake. The shares were acquired via stock plan options exercised on April 29, 2025, and the sale is planned for May 14, 2026. This is a clean-out sale by a former insider, which is notable given the stock's recent strong performance (+39% over the past month) and the lack of any disclosed hedging or diversification rationale.

Key Facts

  • Former CFO Peter J. Kuipers filed Form 144 to sell 886,341 shares of CLOV
  • Estimated sale value: ~$3.06M based on filing date price of ~$3.45/share
  • Shares were acquired via stock plan option exercise on April 29, 2025
  • Sale planned for May 14, 2026 — immediate execution window
  • This appears to be a clean-out sale of Kuipers' entire remaining position
  • Stock has rallied ~39% in the past month (T+20 alpha +29.69% on prior neutral report)

Financial Impact

~$3.06M sale representing 100% of Kuipers' disclosed holdings; ~0.16% of CLOV's $1.9B market cap

insider sellingdilution

Risk Factors

  • Form 144 is an intent to sell — the sale may not be executed
  • Kuipers is a former CFO, not a current executive, so signal may be weaker
  • Stock has strong analyst consensus (60% bullish) and recent positive momentum
  • Small relative size (~0.16% of market cap) limits direct price impact

Market Snapshot

Exchange
Nasdaq
Sector
Hospital & Medical Service Plans
Analyst Consensus
60% bullish (10 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-003605
Document: 0001959173-26-003605-index.html0001959173-26-003605
Document: 0001959173-26-003605.txt0001959173-26-003605
18 reports for CLOV
Performance horizon
67% Hit rate 2 of 3 directional calls best @ T+5▲ +2.36%Aug 17, 2026
Filters
Rows
Reports for CLOV — sortable, filterable
TypeNow
Sep 15, 2026
16d ago
Insider Cluster
NEUTRAL ★ 2/10
$4.56 $4.57▲ +0.22%▼ −2.34%$4.41 (−3.40%)
Aug 17, 2026
6w ago
Insider Cluster
BEARISH ★ 5/10
$4.23 $4.13▲ +2.36%▲ +2.16%$4.41 (−4.14%)
Aug 11, 2026
7w ago
Court Ruling
NEUTRAL ★ 4/10
$4.39 $4.23▼ −3.64%▼ −3.24%$4.41 (+0.34%)
Jul 20, 2026
10w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.79 $4.27▼ −10.86%▼ −9.63%$4.41 (−8.04%)
Jul 17, 2026
11w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 16, 2026
11w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.62 $4.55▼ −1.52%▼ −0.83%$4.41 (−4.65%)
Jul 9, 2026
12w ago
Insider Cluster
NEUTRAL ★ 3/10
$4.68 $4.40▼ −5.98%▼ −5.85%$4.41 (−5.88%)
Jul 6, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$5.00 $4.82▼ −3.60%▼ −4.15%$4.41 (−11.90%)
Jun 17, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$4.80 $5.21▲ +8.54%▲ +9.58%$4.41 (−8.23%)
Showing 10 of 18

US Market Status

Market Open — Closes in 2h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access